November 11th, 2023
This conference has already taken place.
Description
New pharmacology therapies and procedures are increasingly being done for therapies on the heart. These new treatment therapies are being utilized in cardio-oncology, electrophysiology, heart failure, Interventional cardiology, preventive cardiology, and sometimes multiple therapies or clinical areas are partnering together in diagnosing and treating heart ailments. This continuing medical education activity will address the gaps in primary and internal medicine care that occur when new therapies become available.
Dates and Times
Start: 11/11/2023 7:30 AM
End: 11/11/2023 12:00 PM
Objectives
At the conclusion of this continuing medical education activity participants will be able to:
1. Recognize a smorgasbord of symptoms that collectively can lead to a diagnosis of cardiac amyloidosis;
2. Discuss the value in monitoring subtle shifts in pulmonary artery pressures allowing for early intervention of decompensation;
3. Explain criteria for patient selection and management for left atrial appendage occlusion devices;
4. Review the best management of cardiovascular diseases prior to conception, during and after pregnancy;
5. Identify the latest treatment options for atrial fibrillation
Agenda
Pricing
| Tier | Price |
|---|---|
| Physician | $0.00 |
| Nurse/Nurse Practitioner | $0.00 |
| Physician Assistant | $0.00 |
| Allied Health Professional | $0.00 |
| Other | $0.00 |
Location
The Ohio State University Lima Branch
Reed Hall
4240 Campus Drive
Lima, OH 45804
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.